CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ExtruLubTM is a novel extrusion technology that modifies catheter surfaces to reduce friction and enhance safety without altering core properties. This innovation aims to improve medical device performance and reduce manufacturing costs, benefiting the MedTech industry.
ExtruLubTM is an innovative, disruptive extrusion technology applicable across a range of polymer resins, which can change the surface of a catheter without affecting core device properties.
The technology fits in the component sub-supply market with an initial global market of €564 mn applicable across all catheter markets, the latter estimated to reach $42.5 bn globally by 2020.
From a functional perspective, it has the ability to reduce surface friction, generate protective antimicrobial & an…
DIANIA TECHNOLOGIES LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
